SCHEMBL30095433

SCHEMBL30095433

COc1ccc(Cn2cc(Br)c3ccc(N)cc3c2=O)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.44
TP53 P04637 2/20 0.44
LMNA P02545 2/20 0.44
ROCK2 O75116 1/20 0.43
ROCK1 Q13464 1/20 0.43
MAPK10 P53779 3/20 0.42
ALDH1A1 P00352 1/20 0.42
CMA1 P23946 1/20 0.41
PARK7 Q99497 1/20 0.40
HDAC1 Q13547 2/20 0.40
HDAC2 Q92769 2/20 0.40
HDAC6 Q9UBN7 2/20 0.40
USP2 O75604 1/20 0.40
GSK3A P49840 1/20 0.40
GSK3B P49841 1/20 0.40
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28899159 1.00 MAPT (0.44) MAPTTP53LMNAROCK2ROCK1
SCHEMBL14915956 0.78 MAPK8 (0.52) MAPTTP53LMNAALDH1A1
SCHEMBL4678834 0.77 MEN1 (0.46) MAPTTP53LMNAMAPK10ALDH1A1
SCHEMBL15010499 0.77 MAPK8 (0.47) MAPTTP53LMNACMA1PARK7
SCHEMBL2315834 0.76 MMP13 (0.64) ROCK2ROCK1HDAC1HDAC2HDAC6
SCHEMBL31381672 0.76 MAPK10 (0.49) MAPTTP53LMNAMAPK10ALDH1A1
SCHEMBL19679824 0.76 MAPK10 (0.52) MAPTTP53LMNAMAPK10ALDH1A1
SCHEMBL28899220 0.74 LMNA (0.43) MAPTTP53LMNAMAPK10ALDH1A1
SCHEMBL30095522 0.74 LMNA (0.43) MAPTTP53LMNAMAPK10ALDH1A1
SCHEMBL30283377 0.74 EGLN1 (0.45) MAPTTP53MAPK10ALDH1A1HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109456308-B Heterocyclic compounds as ASK inhibitors and their use 南京圣和药业股份有限公司 2022-11-29 CN disclosed